EDOC


Telemedicine & Digital Health ETF

Fund Summary

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

Fund Objective

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Why EDOC?

High Growth Potential

EDOC enables investors to access high growth potential through companies at the leading edge of a structural trend affecting the global health care industry.

Unconstrained Approach

EDOC's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, EDOC delivers access to dozens of companies with high exposure to the telemedicine & digital health theme.

Fund Details As of 03/31/21

Key Facts

Ticker EDOC
Inception Date 07/29/20
CUSIP 37954Y285
ISIN US37954Y2853
Bloomberg Index Ticker SOLEDOC
Primary Exchange Nasdaq
Number of Holdings 39

Stats & Fees

Net Assets $804,207,512
Net Asset Value (NAV) $19.10
Shares Outstanding 42,100,000
Total Expense Ratio 0.68%

Distributions

30-Day SEC Yield -0.40%
Distribution Frequency Semi-Annually

Fund Prices As of 03/31/21

NAV $19.10 Daily Change $0.43 2.31%
Market Price $19.12 Daily Change $0.40 2.14%
30-Day Median Bid-Ask Spread 0.20%

Performance History

As of recent
(12/31/20)
Fund NAV Market Price Index
Year-to-Date -- -- --
1 Month 4.76% 4.65% 4.81%
3 Months 15.01% 14.53% 15.21%
Since Inception 26.63% 26.63% 26.91%
Year-to-Date 4.46% 4.51% 4.52%
1 Month -1.71% -1.61% -1.68%
3 Months 9.43% 9.37% 9.55%
Since Inception 32.28% 32.35% 32.65%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 04/01/21

Return on Equity 14.10%
Weighted Avg. Market Cap 15,840 M
2020 2021
Price-to-earnings 78.67 66.72
Price-to-book value 10.03 8.83

Source: AltaVista Research, LLC

Sector Breakdown As of 03/31/21

% of Net Assets
Health Care 58.9
Information Technology 31.4
Industrials 3.7
Communication Services 3.6
Financials 1.4
Materials 1.0

Source: AltaVista Research, LLC

Country Breakdown As of 03/31/21

% of Net Assets
United States 84.0
Hong Kong 3.7
Japan 3.6
China 3.4
Netherlands 2.4
Germany 1.8
Australia 1.1

Source: AltaVista Research, LLC

Top Holdings As of 04/01/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
4.97 GH GUARDANT HEALTH INC BFXC911 156.99 259,792 40,784,746.08
4.87 NUAN NUANCE COMMUNICATIONS INC 2402121 44.91 890,100 39,974,391.00
4.48 OMCL OMNICELL INC 2789523 134.72 273,123 36,795,130.56
4.38 A AGILENT TECHNOLOGIES INC 2520153 127.50 282,347 35,998,113.11
4.35 ILMN ILLUMINA INC 2613990 385.04 92,673 35,682,811.92
4.33 LH LABORATORY CP 2586122 252.70 140,654 35,543,265.80
4.06 NEO NEOGENOMICS INC 2598246 48.53 687,647 33,371,508.91
4.05 PODD INSULET CORP B1XGNW4 264.82 125,623 33,267,482.86
4.05 CHNG CHANGE HEALTHCARE INC BK5CVS5 22.39 1,483,696 33,219,953.44
3.79 241 HK ALIBABA HEALTH BRXVS60 2.98 10,442,300 31,086,866.42
3.75 2413 JP M3 INC B02K2M3 72.87 422,309 30,772,045.49
3.66 DXCM DEXCOM INC B0796X4 365.50 82,227 30,053,968.50
3.60 CERN CERNER CORP 2185284 72.70 406,259 29,535,029.30
3.56 1833 HK PING AN HEALTHCA BDRYVB3 13.28 2,200,400 29,230,197.07
3.32 PINC PREMIER INC-CLASS A BDZDRC5 34.76 784,968 27,285,487.68
3.26 VEEV VEEVA SYSTEMS INC-CLASS A BFH3N85 267.77 99,910 26,752,900.70
3.10 NVTA INVITAE CORP BVVCNT1 39.19 649,033 25,435,603.27
2.81 TDOC TELADOC HEALTH INC BYQRFY1 182.79 126,444 23,112,698.76
2.73 TNDM TANDEM DIABETES CARE INC BF3W461 87.63 255,487 22,388,325.81
2.37 SAE GR SHOP APOTHEKE EUROPE NV BYYH7G9 219.80 88,445 19,440,633.31
2.28 VCYT VERACYTE INC BFTWZY0 52.72 354,912 18,710,960.64
2.25 RCM R1 RCM INC BD8PMK1 24.98 740,118 18,488,147.64
2.16 IRTC IRHYTHM TECHNOLOGIES INC BYT4ST5 137.21 129,195 17,726,845.95
2.10 ONEM 1LIFE HEALTHCARE INC BKMG1N5 41.23 417,976 17,233,150.48
1.93 MDRX ALLSCRIPTS HEALT 2710039 15.35 1,031,063 15,821,661.74
1.81 COP GR COMPUGROUP MEDIC BMY7CH1 85.85 172,792 14,834,547.81
1.73 INOV INOVALON HOLDINGS INC - A BVV9XH0 29.67 478,603 14,200,151.01
1.43 EHTH EHEALTH INC B1G0F83 74.13 157,961 11,709,648.93
1.38 EVH EVOLENT HEALTH INC - A BYLY8H1 20.67 547,138 11,309,342.46
1.36 PHR PHREESIA INC BKF9DQ8 55.13 202,243 11,149,656.59
1.12 PME AU PRO MEDICUS LTD 6292782 32.91 280,135 9,220,193.69
1.07 CDXS CODEXIS INC B5LL2C2 24.30 361,624 8,787,463.20
0.80 NXGN NEXTGEN HEALTHCARE INC BF5L3D6 18.67 351,233 6,557,520.11
0.77 TRHC TABULA RASA HEAL BYQBFS7 46.90 135,303 6,345,710.70
0.69 OPRX OPTIMIZERX CORP BF5MM09 53.07 106,981 5,677,481.67
0.62 SDC SMILEDIRECTCLUB INC BKT6B38 10.50 483,104 5,072,592.00
0.42 PSNL PERSONALIS INC BJQ0608 24.13 143,767 3,469,097.71
0.33 CPSI COMPUTER PROGRAM 2872122 31.40 87,407 2,744,579.80
0.19 OTRK ONTRAK INC BMVM5X6 32.35 47,094 1,523,490.90
0.11 CASH 1.00 896,577 896,575.33
Holdings are subject to change.


Investing involves risk, including the possible loss of principal. The investable universe of
companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.